Security key
753018100
Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI)
CUSIP: 753018100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Common Stock, Par Value $.0001
- Shares outstanding
- 98,437,808
- Total 13F shares
- 3,108,475
- Share change
- -345,309
- Total reported value
- $11,809,884
- Put/Call ratio
- 13%
- Price per share
- $3.80
- Number of holders
- 33
- Value change
- -$1,252,441
- Number of buys
- 13
- Number of sells
- 12
Report period
Q2 2024
Institutions
33
Top holders
10
RANI full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Rani Therapeutics Holdings, Inc. SEC filings
Rani Therapeutics Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 753018100
Recent filing periods:
Top shareholders of RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.7%
|
685,303
|
$2,131,292 | — | 31 Mar 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.5%
|
493,584
|
$1,535,046 | — | 31 Mar 2024 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.49%
|
481,300
|
$1,496,843 | — | 31 Mar 2024 | |
| Alphabet Inc. |
13F
|
Company |
0.46%
|
448,492
|
$1,394,810 | — | 31 Mar 2024 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
0.34%
|
338,679
|
$1,053,292 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.13%
|
132,434
|
$411,866 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
130,906
|
$407,223 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
124,505
|
$387,211 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.07%
|
70,300
|
$219,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
63,583
|
$197,743 | — | 31 Mar 2024 | |
| Marc Lasry |
13F
|
Individual |
0.06%
|
62,887
|
$195,579 | — | 31 Mar 2024 | |
| KING LUTHER CAPITAL MANAGEMENT CORP |
13F
|
Company |
0.06%
|
56,129
|
$174,561 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
51,500
|
$160,165 | — | 31 Mar 2024 | |
| MOTCO |
13F
|
Company |
0.05%
|
48,129
|
$149,681 | — | 31 Mar 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.03%
|
33,911
|
$105,463 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
33,742
|
$104,938 | — | 31 Mar 2024 | |
| Alpha Square Group S LLC |
13F
|
Company |
0.03%
|
33,401
|
$103,877 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
25,988
|
$80,823 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
22,587
|
$70,000 | — | 31 Mar 2024 | |
| Lafayette Investments, Inc. |
13F
|
Company |
0.02%
|
19,893
|
$61,868 | — | 31 Mar 2024 | |
| CHOREO, LLC |
13F
|
Company |
0.02%
|
19,813
|
$61,618 | — | 31 Mar 2024 | |
| Prime Capital Investment Advisors, LLC |
13F
|
Company |
0.01%
|
13,882
|
$43,173 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
12,686
|
$39,454 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
10,032
|
$31,200 | — | 31 Mar 2024 | |
| Activest Wealth Management |
13F
|
Company |
0.01%
|
9,800
|
$30,478 | — | 31 Mar 2024 | |
| ISLAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
9,611
|
$29,890 | — | 31 Mar 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
9,116
|
$28,351 | — | 31 Mar 2024 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
3,119
|
$9,701 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,000
|
$9,330 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,451
|
$7,623 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,364
|
$4,000 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,239
|
$3,853 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
312
|
$970 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
103
|
$320 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
39
|
$121 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
3
|
$9 | — | 31 Mar 2024 | |
| Isidoro Quiroga Moreno |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
19,890,581
|
$45,151,619 | — | 30 Jul 2021 | |
| InCube Labs, L.L.C. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
13,923
|
$31,605 | — | 03 Feb 2022 | |
| Cortes Isidoro Alfonso Quiroga |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,400
|
$19,068 | — | 24 Nov 2023 | |
| Eric Groen |
3/4/5
|
General Counsel |
—
mixed-class rows
|
486,716
mixed-class rows
|
$370,500 | — | 21 Mar 2024 | |
| Lyn Baranowski |
3/4/5
|
Director |
—
class O/S missing
|
22,240
|
— | — | 25 May 2022 |
Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) as of Q2 2024
As of 30 Jun 2024,
Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,108,475 shares.
The largest 10 holders included
VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, Alphabet Inc., UNITED SERVICES AUTOMOBILE ASSOCIATION, TAKEDA PHARMACEUTICAL CO LTD, GEODE CAPITAL MANAGEMENT, LLC, STIFEL FINANCIAL CORP, BANK OF AMERICA CORP /DE/, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and BlackRock Inc..
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
35
Q2 2024 holders
33
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.